Detalles de la búsqueda
1.
Development and application of a weighted change score to evaluate interventions for vasomotor symptoms in patients with breast cancer using regression trees: a cohort study.
Breast Cancer Res Treat
; 2024 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38763972
2.
2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
Support Care Cancer
; 32(5): 280, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594320
3.
Pre-medication protocols for the prevention of paclitaxel-induced infusion related reactions: a systematic review and meta-analysis.
Support Care Cancer
; 30(7): 5627-5644, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35150312
4.
Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers.
Support Care Cancer
; 30(5): 3977-3984, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35059864
5.
Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review.
Support Care Cancer
; 29(2): 925-943, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32535678
6.
Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer.
Cancer
; 125(7): 1038-1049, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30548240
7.
Lung cancer's real adjuvant EGFR targeted therapy questions.
Lancet Oncol
; 19(1): 15-17, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29174309
8.
The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care.
Curr Oncol
; 31(3): 1376-1388, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534937
9.
A narrative review from gut to lungs: non-small cell lung cancer and the gastrointestinal microbiome.
Transl Lung Cancer Res
; 12(4): 909-926, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37197624
10.
Temozolomide Chronotherapy in Glioma: A Systematic Review.
Curr Oncol
; 30(2): 1893-1902, 2023 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36826108
11.
A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer.
Curr Oncol
; 30(8): 7384-7397, 2023 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37623016
12.
Association of anticoagulant use with clinical outcomes from crizotinib in ALK- and ROS1-rearranged advanced non-small cell lung cancers: A retrospective analysis of PROFILE 1001.
Cancer Med
; 11(23): 4422-4429, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35510711
13.
The current landscape of systemic therapy for recurrent glioblastoma: A systematic review of randomized-controlled trials.
Crit Rev Oncol Hematol
; 169: 103540, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34808376
14.
Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey.
J Bone Oncol
; 26: 100339, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33294318
15.
A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer.
Curr Oncol
; 28(6): 5073-5083, 2021 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34940066
16.
Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient Survey.
Curr Oncol
; 28(6): 5215-5226, 2021 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34940075
17.
Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer.
Curr Oncol
; 28(3): 1847-1856, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34068083
18.
Prospective Observational Study Revealing Early Pulmonary Function Changes Associated With Brigatinib Initiation.
J Thorac Oncol
; 16(3): 486-491, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33307191
19.
Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation.
J Bone Oncol
; 27: 100351, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33680749
20.
Chemotherapy-Induced Nausea and Vomiting: Time for More Emphasis on Nausea?
Oncologist
; 20(6): 576-83, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25948677